MedTrace Logo

Chemotherapy Plus Surgery in Treating Children at Risk of or With Stage I Wilms' Tumor

NCT00003804 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 350

Last updated 2014-06-24

No results posted yet for this study

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. It is not yet known which regimen of chemotherapy is more effective for stage I Wilms' tumor.

PURPOSE: Randomized phase III trial to study the effectiveness of chemotherapy and surgery in treating children who are at risk of or who have stage I Wilms' tumor.

Conditions

Interventions

BIOLOGICAL

dactinomycin

DRUG

vincristine sulfate

PROCEDURE

conventional surgery

Sponsors & Collaborators

  • University of Leicester

    lead OTHER

Principal Investigators

  • Jan DeKraker, MD · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT

Eligibility

Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1993-07-31

Countries

  • Belgium
  • Croatia
  • Czechia
  • Denmark
  • France
  • Greece
  • Italy
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Slovenia
  • Spain
  • Sweden
  • United Arab Emirates

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00003804 on ClinicalTrials.gov